The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

Nov 7, 2026 - 18:00
 0  0
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow